FIELD: medicine.
SUBSTANCE: invention refers to immunology, and concerns recombinant immunotoxin specific to cells expressing HER2 receptor. Recombinant immunotoxin comprises guide module in the form of antibody in scFv format, including variable domains of light and heavy chains of monoclonal humanised HER2-specific antibody interconnected by linker, and toxic module as a fragment of pseudomonal A ETA exotoxin. Guide module is presented with antibody 4D5scFv, recombinant immunotoxin comprises flexible hydrophilic hinge-like linker connecting guide module 4D5scFv with toxic ETA module, and KDEL sequence on C-end of the molecule, and recombinant immunotoxin is presented as SEQ ID NO sequence: 2.
EFFECT: using the given recombinant immunotoxin increases toxicity for cells expressing receptor HER2, and, consequently, therapeutic effectiveness.
4 cl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT TARGET TOXIN SPECIFIC TO HER2 RECEPTOR EXPRESSING CELLS | 2016 |
|
RU2627215C1 |
RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM | 2006 |
|
RU2412253C2 |
SINGLE-DOMAIN MINI-ANTIBODY aHER2/aSKBR3-1, SPECIFICALLY BINDING EPIDERMAL GROWTH FACTOR RECEPTOR HER2/ERBB2/neu AND CAPABLE TO PENETRATE THROUGH THIS INTERACTION INTO TARGET CELLS (INTERNALISED), METHOD OF PRODUCTION OF THIS ANTIBODY AND METHOD OF DETECTION OF PROTEIN HER2/ERBB2/neu AND CELLS EXPRESSING THIS PROTEIN IN INCREASED AMOUNT, USING MINI-ANTIBODY aHER2/aSKBR3-1 | 2012 |
|
RU2522929C2 |
COMPOSITION AND METHOD FOR TREATING NEOPLASTIC CELLS | 1993 |
|
RU2130780C1 |
METHOD OF PRODUCING RECOMBINANT ANTI-TUMOR TOXIN BASED ON PROTEIN BARNASE-BARSTAR AND TARGETED POLYPEPTIDE DARPIN WITH EFFECT OF INSTANT CANCELLATION OF CYTOTOXIC ACTION | 2015 |
|
RU2610179C1 |
RECOMBINANT IMMUNOTOXIN AIMED AT MESOTHELIN | 2012 |
|
RU2600067C2 |
PSCA-CAR-YT CELL LINE HAVING SURFACE EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND EXHIBITING CYTOTOXIC ACTIVITY ON PSCA-POSITIVE HUMAN CANCER CELLS | 2018 |
|
RU2712901C1 |
RECOMBINANT PLASMID DNA pPA-OPRF-ETA CODING SYNTHESIS OF RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa, STRAIN Escherichia coli PA-OPRF-ETA PRODUCING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa AND METHOD FOR PREPARING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa | 2012 |
|
RU2529359C2 |
METHOD FOR ELIMINATING UNDESIRABLE TARGET CELLS | 1997 |
|
RU2182493C2 |
TRANSGENIC GENETIC LABELS AND METHODS OF USE | 2015 |
|
RU2822461C1 |
Authors
Dates
2016-02-27—Published
2014-10-27—Filed